Skip to main content
logo
Biovica International AB (publ) (STO:BIOVIC.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.4210
0.00 (0.00%)
At close: Jan 21, 2026

Revenue by Product

Millions SEK. Fiscal year is May - Apr.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202011 - 2019
Period Ending
Apr '24 Apr '23 Apr '22 Apr '21 Apr '20 2011 - 2019
DiviTum Kits Research Use Only
3.12M
Log In
Log In
Log In
Log In
Upgrade
DiviTum Kits Research Use Only Growth
-30.63%
Log In
Log In
Log In
Log In
Upgrade
Tests (In Vitro Diagnostics) - United States
2.95M
Log In
Log In
Log In
Log In
Upgrade
Tests (In Vitro Diagnostics) - United States Growth
274.75%
Log In
Log In
Log In
Log In
Upgrade
Research Test
2.28M
Log In
Log In
Log In
Log In
Upgrade
Research Test Growth
14.00%
Log In
Log In
Log In
Log In
Upgrade
DiviTum Kits (In Vitro Diagnostics) - European Union
264.00K
Log In
Log In
Log In
Log In
Upgrade
Blood-based Biomarker Assays
-
Log In
Log In
Log In
Log In
Upgrade
Blood-based Biomarker Assays Growth
-
Log In
Log In
Log In
Log In
Upgrade
Services
-
Log In
Log In
Log In
Log In
Upgrade
Services Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions SEK. Fiscal year is May - Apr.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202011 - 2019
Period Ending
Apr '24 Apr '23 Apr '22 Apr '21 Apr '20 2011 - 2019
United States
7.55M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
35.27%
Log In
Log In
Log In
Log In
Upgrade
Rest of World
536.00K
Log In
Log In
Log In
Log In
Upgrade
Rest of World Growth
80.47%
Log In
Log In
Log In
Log In
Upgrade
European Union
531.00K
Log In
Log In
Log In
Log In
Upgrade
European Union Growth
-61.21%
Log In
Log In
Log In
Log In
Upgrade
Sweden
-
Log In
Log In
Log In
Log In
Upgrade